Setting the Course for Comprehensive Care Navigation in Oncology Evolent experts describe the key pieces of a scalable, comprehensive care navigation program in an article in Evidence-Based Oncology. Read Article
From every angle: Dr. Von Nguyen brings rare background to quest for high-value specialty care Chief Medical Officer Von Nguyen brings a background in value-based payment models, artificial intelligence and health plan operations to Evolent. Read Article
Evolent program achieves 20% reduction in use of low-value oncology regimens Program aims to achieve the best possible treatment outcomes — longer lives with fewer side-effects — without excess financial strain. Read Press Release
Clinical trials must represent those who will receive therapy Real-world patients often experience worse outcomes than those seen in clinical trials. Lack of representation may be one reason, writes Dr. Andrew Hertler. Read Article
The case for shorter radiation therapy courses The evidence supports hypofractionation in many cancer treatment scenarios, but there are still many missed opportunities. Read Article
The uses of AI for population health and patient care Our chief medical officer talks with Urban Health Today about AI’s potential to transform healthcare, as well as the importance of responsible AI use. Read Q&A
Certainty vs. speed: How do patients feel about the tradeoff for new cancer drugs? A recent study offers insights to an under-examined question at the heart of the FDA’s accelerated approval process. Read Article
The future of value-based care Dr. Kamal Golla tells the BRightminds in Healthcare Delivery podcast why specialty care is the next frontier in the movement for greater value. Listen to Podcast
Improving primary care physician and specialist coordination and engagement Dr. Kamal Golla speaks with Urban Health Today about ways to integrate providers so patients receive seamless, whole-person care. Read Q&A
The importance of universal hereditary cancer testing Dr. Sadie Dobrozsi highlights the benefits of pan-cancer testing panels, why they are underused, and what we can do about it. Watch Video
